Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why did he write Jan?

quote - "If there has been a change from the chinese payment method (onelumpsum) then isn't that a material item that must be disclosed?"

Actually, something of the opposite might have occurred, meaning perhaps the numbers were so large that had they received a lump sum maybe we would have had to file a K indicating such, which would have blown the cover of the NDA. By repackaging the settlement into royalties, there is no extraordinary/material event (to PTSC's revenues) and thus the deal can fly under the radar, so to speak.

That may be a real reach, but I still am in the royalty camp at this point. We simply did not turn on a dime and just decide to give licenses away after achieving momentum. That does not register, nor jive with the 'average' license fees plugged to date, IMO.

Share
New Message
Please login to post a reply